Osteoporosis

Latest MedTech News for Centinel and DyAnsys
FDA Approval to Centinel’s Total Disc Replacement Devices; FDA clears DyAnsys’ Neurostimula...

Orthox Obtains MHRA Approval to Commence FFLEX Study  On July 14, 2022, Orthodox Ltd, a clinical-stage company created medical implants to treat orthopedic problems including damaged knee ...


Novel-Upcoming-Osteoporosis-Drugs-Market
What All You Need to Know About Evolving Osteoporosis Therapeutic Landscape?

Osteoporosis can be characterized by a decrease in the density of bone, resulting in fragile bones which can decrease its strength. Osteoporosis leads to an extent of abnormally porous bones that ...


osteoporosis-symptoms-risk-factors-diagnosis-and-treatment-options
How Is Osteoporosis Impacting The Quality Of Life?

Osteoporosis is a significant health burden worldwide and associated with pain and decreased physical, social, and mental well-being. The affected person experiences prolonged immobilisation and l...


Leading-Causes-of-Death-Worldwide
What are the Top Five Leading Causes of Deaths in the World?

The global healthcare system over the past few decades has transformed exponentially. Today we are living twice as long as our ancestors have lived before. Infrastructure development, technologica...


Osteoporosis Market
Emerging drugs bring a positive shift in Global Osteoporosis Market

Osteoporosis is not RARE. As per the International Osteoporosis Foundation (IOF), Osteoporosis affects an estimated 75 million people in Europe, USA and Japan. Approximately 10 million Amer...


World OSTEOPOROSIS Day
World Osteoporosis Day

World OSTEOPOROSIS day, observed on 20th October every year to raise awareness about diagnosis, treatment, protection and prevention of Osteoporosis. This condition develops when bone density ...


Amgen reveals price; Bardy raises $35.5M; Kiadis to Acquire CytoSen; Insitro lands a deal

Amgen reveals the price of EVENITY Amgen has set the price of its newly launched Osteoporosis drug Romosozumab (Evenity). Worth USD 21,900 per annum or USD 1,825 a month, the bone-building dru...


Osteoporosis New Drug
New Osteoporosis Drug promises to rebuild Bone

Osteoporosis is a bone disease that makes bones weak and brittle. Osteoporosis, as the word says itself “porous bones”. As we age, bone density decreases and even mild stress or a light fall can c...


CELIAC DISEASE
Celiac Disease – Intestinal damage of Gluten

Celiac Disease (Gluten-Sensitive Enteropathy) is a chronic, autoimmune, inflammatory disease of the small intestine characterized by damage to the lining of the small intestine and typically leads ...


Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...

ASCO Conference 2022
ASCO Conference 2022

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.